This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fu, Q.
Right arrow Articles by O'Brien, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fu, Q.
Right arrow Articles by O'Brien, C. A.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, September 2006, p. 6453-6468, Vol. 26, No. 17
0270-7306/06/$08.00+0     doi:10.1128/MCB.00356-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Parathyroid Hormone Controls Receptor Activator of NF-{kappa}B Ligand Gene Expression via a Distant Transcriptional Enhancer{dagger}

Qiang Fu, Stavros C. Manolagas, and Charles A. O'Brien*

Division of Endocrinology & Metabolism, Department of Medicine, Center for Osteoporosis & Metabolic Bone Diseases, University of Arkansas for Medical Sciences, and Central Arkansas Veterans Healthcare System, Little Rock, Arkansas, 72205

Received 27 February 2006/ Returned for modification 5 May 2006/ Accepted 12 June 2006

RANKL, a protein essential for osteoclast development and survival, is stimulated by parathyroid hormone (PTH) via a PTH receptor 1/cyclic AMP (cAMP)/protein kinase A (PKA)/CREB cascade, exclusively in osteoblastic cells. We report that a bacterial artificial chromosome-based transcriptional reporter construct containing 120 kb of RANKL 5'-flanking region was stimulated by dibutyryl-cAMP in stromal/osteoblastic cells, but not other cell types. Full cAMP responsiveness was dependent upon a conserved 715-bp region located 76 kb upstream from the transcription start site, which we identified by sequential deletion analysis and by comparison of human and mouse genomic sequences in silico. This region contained conserved consensus sequences which bound CREB and the osteoblast-specific transcription factor Runx2, and when mutated blunted cAMP responsiveness. Overexpression of Runx2 potentiated cAMP responsiveness of the endogenous RANKL gene in a cell-type-specific manner. Lastly, PTH responsiveness of the endogenous RANKL gene was abrogated in mice from which we deleted this conserved upstream region. Thus, PTH responsiveness of the RANKL gene is determined by a distant regulatory region that responds to cAMP in a cell-type-specific manner and Runx2 may contribute to such cell-type specificity.

* Corresponding author. Mailing address: University of Arkansas for Medical Sciences, 4301 W. Markham St., Mail Slot 587, Little Rock, AR 72205. Phone: (501) 686-5607. Fax: (501) 686-8148. E-mail: caobrien{at}uams.edu.

{dagger} Supplemental material for this article may be found at http://mcb.asm.org/.

Molecular and Cellular Biology, September 2006, p. 6453-6468, Vol. 26, No. 17
0270-7306/06/$08.00+0     doi:10.1128/MCB.00356-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Bishop, K. A., Meyer, M. B., Pike, J. W. (2009). A Novel Distal Enhancer Mediates Cytokine Induction of Mouse Rankl Gene Expression. Mol. Endocrinol. 23: 2095-2110 [Abstract] [Full Text]  
  • Sundaram, K., Senn, J., Yuvaraj, S., Rao, D. S., Reddy, S. V. (2009). FGF-2 Stimulation of RANK Ligand Expression in Paget's Disease of Bone. Mol. Endocrinol. 23: 1445-1454 [Abstract] [Full Text]  
  • Galli, C., Fu, Q., Wang, W., Olsen, B. R., Manolagas, S. C., Jilka, R. L., O'Brien, C. A. (2009). Commitment to the Osteoblast Lineage Is Not Required for RANKL Gene Expression. J. Biol. Chem. 284: 12654-12662 [Abstract] [Full Text]  
  • Pike, J. W., Meyer, M. B., Martowicz, M. L. (2009). New Techniques in Transcription Research Extend Our Understanding of the Molecular Actions of the Vitamin D Hormone. IBMS BoneKEy 6: 169-180 [Abstract] [Full Text]  
  • Khalid, O., Baniwal, S. K., Purcell, D. J., Leclerc, N., Gabet, Y., Stallcup, M. R., Coetzee, G. A., Frenkel, B. (2008). Modulation of Runx2 Activity by Estrogen Receptor-{alpha}: Implications for Osteoporosis and Breast Cancer. Endocrinology 149: 5984-5995 [Abstract] [Full Text]  
  • Mathew, S., Lund, R. J., Chaudhary, L. R., Geurs, T., Hruska, K. A. (2008). Vitamin D Receptor Activators Can Protect against Vascular Calcification. J. Am. Soc. Nephrol. 19: 1509-1519 [Abstract] [Full Text]  
  • Nerenz, R. D., Martowicz, M. L., Pike, J. W. (2008). An Enhancer 20 Kilobases Upstream of the Human Receptor Activator of Nuclear Factor-{kappa}B Ligand Gene Mediates Dominant Activation by 1,25-Dihydroxyvitamin D3. Mol. Endocrinol. 22: 1044-1056 [Abstract] [Full Text]  
  • Galli, C., Zella, L. A., Fretz, J. A., Fu, Q., Pike, J. W., Weinstein, R. S., Manolagas, S. C., O'Brien, C. A. (2008). Targeted Deletion of a Distant Transcriptional Enhancer of the Receptor Activator of Nuclear Factor-{kappa}B Ligand Gene Reduces Bone Remodeling and Increases Bone Mass. Endocrinology 149: 146-153 [Abstract] [Full Text]  
  • Ono, N., Nakashima, K., Schipani, E., Hayata, T., Ezura, Y., Soma, K., Kronenberg, H. M., Noda, M. (2007). Constitutively Active Parathyroid Hormone Receptor Signaling in Cells in Osteoblastic Lineage Suppresses Mechanical Unloading-induced Bone Resorption. J. Biol. Chem. 282: 25509-25516 [Abstract] [Full Text]  
  • Lazarenko, O. P., Rzonca, S. O., Hogue, W. R., Swain, F. L., Suva, L. J., Lecka-Czernik, B. (2007). Rosiglitazone Induces Decreases in Bone Mass and Strength that Are Reminiscent of Aged Bone. Endocrinology 148: 2669-2680 [Abstract] [Full Text]  
  • Kim, S., Yamazaki, M., Shevde, N. K., Pike, J. W. (2007). Transcriptional Control of Receptor Activator of Nuclear Factor-{kappa}B Ligand by the Protein Kinase A Activator Forskolin and the Transmembrane Glycoprotein 130-Activating Cytokine, Oncostatin M, Is Exerted through Multiple Distal Enhancers. Mol. Endocrinol. 21: 197-214 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»